Health Care · Surgical & Medical Instruments & Apparatus

OSUR ORASURE TECHNOLOGIES INC SEC Filings & Insider Trading Activity 2026

company
CIK 1116463133 filings
Russell 2000

OSUR at a glance

ORASURE TECHNOLOGIES INC (OSUR, SEC CIK 1116463) filed its latest 10-K annual report on March 9, 2026, a 10-Q quarterly report on November 9, 2026, an 8-K current report on November 9, 2026 and Form 4 insider filings as recently as October 1, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), ORASURE TECHNOLOGIES INC (OSUR) reported revenue of $115.0 million (down 38.1% from FY2024) and a net loss of $68.7 million. Diluted EPS was -$0.94.
  • As of September 30, 2026, 26 institutional investment managers tracked by SignalX reported holding ORASURE TECHNOLOGIES INC (OSUR) shares worth $82.7 million in 13F-HR filings.
  • The most recent insider open-market purchase reported on Form 4 was by Boyd Steven Kyle on May 14, 2026 of 25,000 shares at $2.99 per share.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$115.0M
−38.1% vs prior year
Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
26 funds
$82.7M · +0 vs prior quarter
Latest 8-K
Nov 9, 2026
Item 2.02

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • No material changes to previously disclosed risk factors in the 2025 Form 10-K
  • Carried-forward risks include regulatory compliance, product competition, operational execution, and financial liquidity exposures

Management Discussion & Analysis

  • Q3 revenue $30.9M, up 14% from $27.1M YoY
  • Gross margin 45.2% vs 43.5% YoY; operating loss $13.0M vs $16.1M
  • Best segment: Sample Management Solutions, $12.5M, up 21% from $10.3M
  • Cash $148.2M vs $199.3M at December 31, 2025; operating cash use $34.7M
  • Capital deployment: $5.0M investing outflow, $8.6M financing outflow including $7.0M stock repurchases

AI summary of the OSUR 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 9, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • OraSure announced consolidated results for the quarter ended September 30, 2026
  • Detailed financial results and management commentary are contained in Exhibit 99.1

Item EX-99.1: Item EX-99.1

  • Q3 revenue $30.9M, up 14% year over year, led by Diagnostics growth of 16% and Sample Management Solutions growth of 21%
  • GAAP gross margin expanded to 45.2% from 43.5%, reflecting operational efficiencies and improved fixed-cost absorption
Filed Aug 5, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Q2 revenue $30.6M, down 2% YoY but up 9.7% sequentially, exceeding guidance and signaling early recovery
  • Diagnostics revenue $19.4M, up 1% YoY, while COVID-19 revenue fell 96% to $1,000 and risk-assessment revenue ended

Item 2.02: Results of Operations and Financial Condition

  • Q2 2026 results for quarter ended June 30, 2026 announced August 5, 2026
  • Consolidated financial details and management commentary contained in Exhibit 99.1 press release
Filed Jun 11, 2026Full analysis →

Item 8.01: Other Events

  • FDA clearance expands Colli-Pee™ Dx use with Roche STI tests for four infections
  • Compatibility covers Roche cobas 5800, 6800, and 8800 molecular diagnostic systems

AI summaries of OSUR 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for OSUR

Don't miss the next OSUR filing

  • Alerts as it files. A push when OSUR files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut OSUR, by share count.
  • Ask anything. An AI agent that reads every OSUR filing and answers with sources.

OSUR alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Boyd Steven KyleASep 29, 2026$3.88
Kenny John P.FSep 6, 2026$3.43
Boyd Steven KyleAJun 26, 2026$4.43
Boyd Steven KyleAJun 3, 2026-
Kenny John P.AJun 3, 2026-
McMahon Robert W.AJun 3, 2026-
Gagliano Nancy JAJun 3, 2026-
Marmora LelioAJun 3, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$185.8M$115.0M
Gross Profit-$79.4M$48.2M
Operating Income--$28.3M-$72.0M
Net Income--$19.5M-$68.7M
Gross Margin-42.7%41.9%
Op. Margin--15.2%-62.6%
Net Margin--10.5%-59.8%
Balance Sheet
Total Assets$482.8M$479.7M$403.2M
Equity$430.7M$410.3M$340.8M
ROE--4.8%-20.2%
Per Share
EPS-$-0.26$-0.94
Cash Flow
Operating CF-$27.4M-$49.0M
CapEx-$3.8M$4.2M

Source: XBRL data in ORASURE TECHNOLOGIES INC (OSUR)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate OSUR share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
OSUR shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202626$82.7M
Q2 202626$95.1M
Q1 202626$66.5M
Q4 202522$59.0M
Q3 202524$93.3M
Q2 202527$81.5M
Q1 202525$77.4M
Q4 202422$76.0M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 198 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

OSUR filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
10-QNov 9, 2026Analysis
8-KNov 9, 2026Analysis-
4Oct 1, 2026--
SC 13DSep 17, 2026-
4Sep 9, 2026--
SC 13GAug 12, 2026-
10-QAug 7, 2026Analysis
8-KAug 5, 2026Analysis-
4Jun 30, 2026--
8-KJun 11, 2026Analysis-
4Jun 5, 2026-
4Jun 5, 2026-
4Jun 5, 2026-
4Jun 5, 2026-
4Jun 5, 2026-
4Jun 5, 2026-
8-KJun 3, 2026Analysis
4May 14, 2026-
4May 14, 2026-
4May 14, 2026-
4May 14, 2026-
4May 14, 2026-
10-QMay 8, 2026Analysis
8-KMay 6, 2026Analysis
SC 13GApr 30, 2026-

Related Health Care companies

All Health Care →

OSUR SEC filings: frequently asked questions

Which institutions hold OSUR stock?

As of September 30, 2026, the largest ORASURE TECHNOLOGIES INC (OSUR) holders among the 13F filers tracked by SignalX were BlackRock ($23.8 million), Vanguard Capital Management LLC ($11.4 million), Dimensional Fund Advisors ($8.8 million), Renaissance Technologies LLC ($7.7 million), State Street Corp ($6.5 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was OSUR's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), ORASURE TECHNOLOGIES INC (OSUR) reported revenue of $115.0 million (down 38.1% from FY2024) and a net loss of $68.7 million. Diluted EPS was -$0.94. The figures come from the XBRL data in the 10-K.

What did OSUR report in its latest 8-K?

ORASURE TECHNOLOGIES INC (OSUR) filed an 8-K on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). OraSure announced consolidated results for the quarter ended September 30, 2026.

What are the latest OSUR SEC filings?

ORASURE TECHNOLOGIES INC (OSUR) filed its latest 10-K annual report on March 9, 2026, a 10-Q quarterly report on November 9, 2026, an 8-K current report on November 9, 2026 and a Form 4 insider filing on October 1, 2026.

What is OSUR's SEC CIK number?

ORASURE TECHNOLOGIES INC (OSUR)'s SEC Central Index Key (CIK) is 1116463. EDGAR lists every OSUR filing under that number.

Ask anything about OSUR

The research agent reads OSUR's filings, financials, insider trades and 13F holders, then answers with sources.